< Back to latest news & events

News

EPO Fees – changes applying from 1 April 2022

February 2022

The EPO has announced the revised EPO Fees that will apply from 1 April 2022 in its Official Journal. The new amounts will apply to payments made on or after 1 April 2022. Many fees, including renewals fees, will increase by around 3%. A summary of the new fees is show below. In some cases, applicants may want to consider the timing for paying fees in relation to their applications to maximise any opportunities to pay lower official fees. If you would like advice on this, please contact your usual HGF Attorney.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

UK IPO Update to AI Patenting Guidelines Highlights Difficulties in Protecting Core AI Inventions

The release by a Chinese company, DeepSeek, of a new open-source reasoning model, has led to falls of hundreds of billions of dollars in US technology stocks including at one …

Read article

UPC stakes claim for wide-reaching long-arm jurisdiction for European patents

Fujifilm Corporation v Kodak GmbH & ors – Thomas J, Dr Thom J and Dr Parchmann J.  – UPC_CFI_355/2023 –  28 January 2025 The Düsseldorf Local Division has delivered the …

Read article

IP Ingredients: The not so "Impossible" Burger

Meat alternatives are a hot topic with the increase in popularity of vegetarianism and veganism, highlighted by this month being “veganuary”.  However, at time when meat alternatives are coming under …

Read article

WTR 1000 2025

We are proud to announce that our European trade mark team has been recognised in the World Trade Mark Review 1000 2025. The firm is also proud to have 19 …

Read article

Court of Appeal Confirms No Second Medical Use SPCs in UK

Merck Serono SA  v  The Comptroller-General of Patents, Designs, and Trade Marks – Lewison LJ, Arnold LJ and Birss LJ – [2025] EWCA Civ 45 – 28 January 2025 The …

Read article

T 0295/22: Apremilast decision highlights hopes and challenges for broad second medical use claims

This case provides insight to the EPO’s interpretation of administration features in second medical use claims. Whilst the door appears to be open for broader second medical use claims, they …

Read article
See all updates